Plexus Research, a division of GP InnoVentures (GPIV), an investment and innovation organization based in Adelaide,...
Autoimmune diseases are typically caused when the immune system, whose purpose is to deal with foreign threats to the bo...
KCR, the international clinical development solutions provider has announced the establishment of a new branch in Sydney...
Polyacrylamide gel electrophoresis enables high-resolution separation of proteins extracted from biological samples, but...
While the World Health Organization (WHO) continues its mission to Wuhan investigating the origin and early transmission...
Gilead Sciences announced on Feb 4, 2021, at the 2021 Asian Pacific Association for the Study of the Liver Con...
ImmVira Group Company, a biotechnology platform dedicated to the development of oncolytic virus(OV) and vector type appr...
Exact Sciences Corp. on 9 Dec 2020 announced that data from the Rx for Positive Node, Endocrine Responsive Breast Cancer...
Hummingbird Bioscience, an innovative clinical-stage biotech company in Singapore and US focused on developing revolutio...
Researchers from the National University of Singapore (NUS) have developed a new way to treat sewage that is much simple...
Japanese firm SUSMED, Inc. has announced that it has received a response from both the Ministers of Health, Labor, ...
France-based Kayentis, a global provider of digital data capture systems for clinical trials, on 2 Dec 2020 announc...
Gilead Sciences, Inc. on 16 Nov 2020 announced the recipients of its first Asia HIV Research Scholar Program. The P...
A joint study by the National Neuroscience Institute (NNI) and Singapore General Hospital (SGH) revealed that patients w...
PPD, Inc., a leading global contract research organization headquartered in the US, is opening a new laboratory in Suzho...
TaiGen Biotechnology Company, Limited ("TaiGen") announced on 5 Oct 2020 that it has filed an Investigational New Drug (...
The Asia-Pacific region is fast emerging as one of the significant regions for clinical trials, with a study by Glo...
Pharma companies around the world are exploring innovative approaches to develop therapeutics and vaccines against COVID...
A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan...
Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc...
Singapore's Concept Medical Inc., focused on vascular intervention drug delivery devices, on 15 Sep 2020 has a...
Taiwan's Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Re...
Full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with ...
Duke-NUS, the only graduate-entry medical school in Singapore, has joined the US based TriNetX global research netw...
The global company BeiGene, Ltd. and Beijing based Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd., ha...
CStone Pharmaceuticals Co., Ltd. on 31 August 2020 announced that the US Food and Drug Administration (FDA) ha...
Belgium based Europital, the global provider of medical management services for clinical research and drug dev...
Novotech, the largest biotech specialist CRO in the Asia-Pacific region, was awarded the ‘2020 Frost & Su...
Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first p...
The Global Virus Network (GVN), a coalition comprised of the world's preeminent human and animal, announced that...
A Two-part Phase I Study With the Antibody-drug Conjugate SYD985 in Combination With Niraparib to Evaluate Safety, Pharm...
AUM Biosciences (AUM), a Singapore-headquartered clinical-stage biopharmaceutical company aiming to democratize R&D ...
Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...
Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and gen...
South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...
US based Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the di...
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Av...
BellaSeno GmbH, an ISO 13485-certified clinical-stage medtech company developing absorbable scaffolds using additiv...
The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacifi...
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivot...
Swedish firm Lipidor AB has announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical compan...
Alterity Therapeutics announced that it has received guidance from the US Food and Drug Administration (FDA) in relation...
Panthera and Rutherford Health plc have entered a collaboration to create a network of world-class clinical trial sites ...
The leading Asia-Pacific biotech specialist CRO Novotech has partnered with South Korea’s world-class 1,...
Government Medical College and Hospital (GMCH) of Nagpur, Maharastra, India, will serve as the lead site for the “...
The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital on 10 June 2020 that Australia current...
The Australian CRO, Avance Clinical, said there was a 34% increase in the number of international trials registered in A...
Daewoong Pharmaceutical (Daewoong) from South Korea unveiled for the first time the phase 3 clinical data of Fexupr...
Taiwan based TWi Biotechnology (TWiB) announced that they have received Clinical Trial Application (CTA) approval f...
Regeneron and Sanofi recently announced the preliminary results from the Phase II portion of an ongoing Phase II/III tri...
Award-winning digital patient recruitment Platform GeoMap Clinical has announced the Patient Enrollment Guarantee for sp...
BioNTech and Pfizer Inc. have disclosed additional details of their collaboration to advance candidates from BioNTech&rs...
Leading Australian CRO Avance Clinical on 3 April 2020 detailed the top reasons it's APAC biotechs selected Australia fo...
The Asia-Pacific (APAC) has emerged as the most prominent region for conducting clinical trials, accounting for over 40%...
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced on 2 April 2020 that it has appointed US-base...
"Spain and Norway are ready to enrol their patients for COVID-19 clinical trial", announces Dr Tedros Adhanom Ghebreyesu...
Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist in two categories for the Citelin...
Australian CRO Avance Clinical has said that Australia’s fast regulatory approval environment, key opinion leader ...
SGX-listed Singapore eDevelopment Ltd has announced that its wholly-owned U.S. biomedical subsidiary Impact BioMedical, ...
Award-winning global leader in digital patient recruitment GeoMap Clinical by TrialWire announced on 11 March 2020 that ...
Asia-Pacific’s largest specialist biotech CRO Novotech has been selected for the Komipharm International clin...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic...
PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...
Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced th...
Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrou...
CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...
French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...
Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...
Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading...
Liver cancer is the fourth most common cancer among men and affects approximately 24 individuals in every 100,000 people...
NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality ...
Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in a...
CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therap...
Seattle Genetics, Inc. and Astellas Pharma Inc.have announced a clinical collaboration agreement with Merck, k...
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves over...
The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epi...
CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrati...
AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the...
A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...
The Singapore Clinical Research Institute (SCRI), on 22 Oct 2019, announce the nine winners of the inaugural Distinguish...
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced on 22 Oct 2019, the...
Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...
ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...
Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...
The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...
Solasia Pharma KK has announced that the darinaparsin Phase 2 study patient registration has reached the targ...
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late...
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that it...
Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of C...
Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has su...
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicine...
Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...
ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announ...
CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II b...
Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication i...
CStone Pharmaceuticals, on 23 August 2019, announced that the Company has recently received ethics approval from the Hum...
Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hy...
The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results fr...
AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that&n...
